Ipca Laboratories has reported 66.98 per cent rise in net profit at Rs 71.77 crore for the first quarter ended June 30, 2013, mainly on account of robust sales.
The company had posted a net profit of Rs 42.98 crore in the corresponding period last fiscal, Ipca Laboratories said in a BSE filing.
Total income from operations rose to Rs 805.56 crore during the quarter under review from Rs 637.61 crore in same period a year-ago.
Revenues from formulations rose to Rs 580.31 crore in FY’14Q1 against Rs 448.69 crore in the same period last fiscal. Revenues from APls also rose to Rs 212.22 crore from Rs 181.56 crore.
Ipca Laboratories has a strong thrust on exports which now account for nearly 61 per cent of its income, the company said.
Shares of Ipca Laboratories were trading at Rs 656.10 apiece in the afternoon trade on the BSE today, up 1.45 per cent from their previous close.